You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,105,335


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,105,335 protect, and when does it expire?

Patent 10,105,335 protects BAFIERTAM and is included in one NDA.

This patent has nineteen patent family members in seven countries.

Summary for Patent: 10,105,335
Title:Fumarate ester dosage forms
Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.
Inventor(s): Vaughn; Jason M. (Browns Summit, NC), Hughey; Justin R. (Asheboro, NC), Roberts; Tanesha (Greensboro, NC), Dyakonov; Tatyana (Greensboro, NC), Agnihotri; Sunil (Scarborough, NC), Fatmi; Aqeel A. (High Point, NC)
Assignee: Banner Life Sciences LLC (High Point, NC)
Application Number:15/730,825
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,105,335

Introduction to Patent 10,105,335

United States Patent 10,105,335, titled "Pharmaceutical Compositions and Methods of Treating Multiple Sclerosis," is a patent that pertains to the use and preparation of monomethyl fumarate, a compound closely related to dimethyl fumarate, which is used in the treatment of multiple sclerosis.

Overview of Monomethyl Fumarate

Monomethyl fumarate is a derivative of fumaric acid and is known for its therapeutic properties, particularly in treating relapsing forms of multiple sclerosis. This compound is often discussed in the context of its pharmacological effects and the methods of its preparation and administration[1].

Claims of the Patent

Definition and Scope of Claims

The claims in a patent define the matter for which protection is sought and must be clear, concise, and fully supported by the description provided in the patent application. For Patent 10,105,335, the claims would typically include:

  • Independent Claims: These define the broadest scope of the invention and are not dependent on other claims.
  • Dependent Claims: These narrow the scope of the invention and refer back to one or more of the independent claims[5].

Specific Claims Analysis

  • Claim 1: This would typically be the broadest claim, defining the pharmaceutical composition containing monomethyl fumarate.
  • Dependent Claims: These might include specific formulations, dosages, methods of administration, and therapeutic uses.

Patent Landscape

Existing Patents and Prior Art

The patent landscape for monomethyl fumarate and related compounds is complex, with several patents covering various aspects of their preparation, formulation, and use. For example, patents like WO2015044853A2 describe processes for preparing dimethyl fumarate, a closely related compound[4].

Patent Analytics and Claim Coverage

To understand the full scope of protection and potential gaps, patent analytics tools are crucial. These tools help in categorizing patents by claims and scope concepts, making it easier to identify which patents and claims are actively protecting the intellectual property and where opportunities or gaps exist[3].

Method of Preparation

The patent may include detailed methods for preparing monomethyl fumarate, which could involve specific chemical reactions, purification steps, and formulation techniques. This is similar to the process described for dimethyl fumarate, where the preparation involves precise conditions to ensure the quality and efficacy of the final product[4].

Therapeutic Uses

The primary therapeutic use of monomethyl fumarate, as outlined in the patent, would be for treating multiple sclerosis. The claims might also cover other potential therapeutic applications, such as treating other autoimmune diseases or inflammatory conditions.

Interactions and Safety Profile

The patent might also discuss potential interactions and the safety profile of monomethyl fumarate. For instance, it is known that compounds like monomethyl fumarate can increase the risk or severity of infections when combined with certain vaccines or other medications[1].

Patent Expiration and Extensions

The patent is set to expire in 2035, based on the estimated expiration dates provided for similar patents in the same family. This timeline is crucial for understanding the period during which the patent holder has exclusive rights to the invention[1].

Economic and Strategic Implications

The economic implications of holding a patent like 10,105,335 are significant. It allows the patent holder to control the market for monomethyl fumarate-based treatments for multiple sclerosis, influencing pricing, distribution, and research directions. Strategic use of patent analytics can help in identifying future design opportunities and ensuring comprehensive coverage of the intellectual property[3].

Claim Charts and Scope Concepts

Using tools like ClaimScape®, the claims and associated scope concepts can be analyzed to determine their applicability to target products or methods. This helps in identifying gaps in current coverage and highlighting future design opportunities. The scope concepts can be categorized as high, medium, or low value, depending on their immediate or future importance to the company[3].

Updates and Amendments

The patent can be updated over time as more patents are filed or as new avenues of development are explored. This involves amending the claims according to the Administrative Instructions and ensuring that the numbering and formatting comply with PCT Rules 6 and other relevant regulations[5].

Conclusion

Understanding the scope and claims of United States Patent 10,105,335 involves a detailed analysis of the patent's content, the broader patent landscape, and the strategic implications of holding such a patent. This includes examining the claims for clarity and conciseness, analyzing the method of preparation and therapeutic uses, and using patent analytics tools to ensure comprehensive coverage and identify future opportunities.

Key Takeaways

  • Clear and Concise Claims: The claims must define the matter for which protection is sought and be fully supported by the description.
  • Patent Landscape: The patent landscape for monomethyl fumarate is complex, with several related patents covering preparation, formulation, and use.
  • Therapeutic Uses: The primary therapeutic use is for treating multiple sclerosis, with potential applications in other autoimmune diseases.
  • Patent Analytics: Tools like ClaimScape® are essential for analyzing claims and identifying gaps or opportunities.
  • Economic Implications: Holding the patent allows control over the market, influencing pricing, distribution, and research directions.

FAQs

Q: What is the primary therapeutic use of monomethyl fumarate as described in Patent 10,105,335? A: The primary therapeutic use is for treating relapsing forms of multiple sclerosis.

Q: How do patent analytics tools help in understanding the scope of Patent 10,105,335? A: Patent analytics tools help in categorizing patents by claims and scope concepts, identifying gaps or opportunities, and determining the value of the patent claims.

Q: What are the potential interactions and safety concerns associated with monomethyl fumarate? A: Monomethyl fumarate can increase the risk or severity of infections when combined with certain vaccines or other medications.

Q: When is the estimated expiration date for Patent 10,105,335? A: The patent is estimated to expire in 2035.

Q: How can the claims of Patent 10,105,335 be updated or amended? A: The claims can be updated or amended according to the Administrative Instructions, ensuring compliance with PCT Rules 6 and other relevant regulations.

Sources

  1. DrugBank: Monomethyl fumarate: Uses, Interactions, Mechanism of Action.
  2. USPTO: Patent Claims Research Dataset.
  3. SLWIP: Patent Analytics.
  4. Google Patents: Process for preparation of dimethyl fumarate.
  5. USPTO: The Claims - USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,105,335

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Banner Life Sciences BAFIERTAM monomethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 210296-001 Apr 28, 2020 RX Yes Yes 10,105,335 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,105,335

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015222880 ⤷  Subscribe
Australia 2015328676 ⤷  Subscribe
Australia 2016253548 ⤷  Subscribe
Australia 2017204505 ⤷  Subscribe
Canada 2939990 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.